These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs. Scheifes A, Walraven S, Stolker JJ, Nijman HL, Egberts TC, Heerdink ER. Res Dev Disabil; 2016; 49-50():13-21. PubMed ID: 26647003 [Abstract] [Full Text] [Related]
12. Movement side effects of antipsychotic drugs in adults with and without intellectual disability: UK population-based cohort study. Sheehan R, Horsfall L, Strydom A, Osborn D, Walters K, Hassiotis A. BMJ Open; 2017 Aug 03; 7(8):e017406. PubMed ID: 28775195 [Abstract] [Full Text] [Related]
15. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations. J Clin Psychiatry; 1998 Aug 03; 59 Suppl 12():23-7. PubMed ID: 9766616 [Abstract] [Full Text] [Related]
16. Antipsychotic induced movement disorders. Ramesh S, Sagar R. Indian J Med Sci; 2001 Sep 03; 55(9):483-7. PubMed ID: 11887297 [No Abstract] [Full Text] [Related]
20. Assessment of Drug-Associated Extrapyramidal Symptoms in People With Intellectual Disability: A Comparison of an Informant-Based Scale With Clinical Rating Scales. de Kuijper GM, Hoekstra PJ. J Clin Psychopharmacol; 2016 Oct 03; 36(5):508-12. PubMed ID: 27529770 [Abstract] [Full Text] [Related] Page: [Next] [New Search]